- Home
- ALEC vs BLDE Comparison
ALEC vs BLDE Comparison
Compare ALEC & BLDE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALEC
- BLDE
- Stock Information
- Founded
- ALEC 2013
- BLDE 2014
- Country
- ALEC United States
- BLDE United States
- Employees
- ALEC N/A
- BLDE N/A
- Industry
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- BLDE Aerospace
- Sector
- ALEC Health Care
- BLDE Consumer Discretionary
- Exchange
- ALEC Nasdaq
- BLDE Nasdaq
- Market Cap
- ALEC 232.6M
- BLDE 276.7M
- IPO Year
- ALEC 2019
- BLDE N/A
- Fundamental
- Price
- ALEC $1.86
- BLDE $3.95
- Analyst Decision
- ALEC Buy
- BLDE Buy
- Analyst Count
- ALEC 6
- BLDE 1
- Target Price
- ALEC $11.75
- BLDE $6.00
- AVG Volume (30 Days)
- ALEC 2.3M
- BLDE 1.6M
- Earning Date
- ALEC 11-06-2024
- BLDE 11-12-2024
- Dividend Yield
- ALEC N/A
- BLDE N/A
- EPS Growth
- ALEC N/A
- BLDE N/A
- EPS
- ALEC N/A
- BLDE N/A
- Revenue
- ALEC $61,508,000.00
- BLDE $241,814,000.00
- Revenue This Year
- ALEC N/A
- BLDE $11.34
- Revenue Next Year
- ALEC $71.71
- BLDE $5.73
- P/E Ratio
- ALEC N/A
- BLDE N/A
- Revenue Growth
- ALEC N/A
- BLDE 12.04
- 52 Week Low
- ALEC $1.73
- BLDE $2.45
- 52 Week High
- ALEC $8.90
- BLDE $5.17
- Technical
- Relative Strength Index (RSI)
- ALEC 22.54
- BLDE 47.19
- Support Level
- ALEC $1.74
- BLDE $3.95
- Resistance Level
- ALEC $2.50
- BLDE $4.45
- Average True Range (ATR)
- ALEC 0.16
- BLDE 0.37
- MACD
- ALEC 0.03
- BLDE -0.08
- Stochastic Oscillator
- ALEC 2.37
- BLDE 11.45
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.
About BLDE Blade Air Mobility Inc.
Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.